Notice of extraordinary general meeting
Filed with HKEX · Stock code 1011 · · 2 pages · English
Summary by 6ix AI
This filing is a notice for an extraordinary general meeting of China NT Pharma Group Co., Ltd. The meeting is scheduled to discuss the appointment of a new auditor and other resolutions. Members are encouraged to appoint proxies to attend and vote on their behalf.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
China NT Pharma Group Co., Ltd. on 6ix
Earlier from China NT Pharma
- Appointment of auditor and notice of extraordinary general meeting
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Notification Letter and Request Form to Non-Registered Holder
- Notification Letter and Reply Form to Registered Shareholder
- 2026 Interim Report
Later from China NT Pharma
- Form of proxy for use at extraordinary general meeting
- Supplemental announcement supplemental information in relation to the annual report for the year ended 31 December 2025
- Voluntary announcement in relation to the application for revocation of the first arbitral award and litigation in respect of the equity interest in beijing kangchen biological technology co., limited
- Quarterly updates on the implementation of action plans to resolve the disclaimer of opinion
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow China NT Pharma into a list and get an email when it puts out news.
Follow China NT Pharma